Back to search results

Whole Selves Study for Young Adults

This study is testing an online program called "Whole Selves" for young adults (ages 18-30) who identify as transgender/nonbinary. Whole Selves is a brief, self-guided program designed to help with alcohol use and romantic relationships. Researchers will first get feedback from 10 young adults to improve the program. Then, 107 young adults will try Whole Selves to see if it's acceptable and how it works. We'll measure changes in alcoholic drinks per week, depression, and anxiety symptoms over 90 days. To join, you need to be able to read and write English, live in the U.S., and be in a romantic relationship that started at least six weeks ago. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 107 participants. It will first involve user testing with 10 young adults, followed by a single-arm feasibility study with 107 young adults.
What's involved
You would participate in a single online session of the Whole Selves intervention, lasting approximately 40 minutes. Your alcohol use, depression, and anxiety symptoms would be measured at the start, 30 days, and 90 days.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 90 days after starting the intervention, with measurements taken at 30 and 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06392542

Whole Selves User Testing and Feasibility Study

Not Yet Recruiting
NAAges 18–30Interventional
Boston University
~107 participants
Updated 2026-07-28 on ClinicalTrials.gov
What's tested:Whole Selves

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Alcoholic drinks per week
Measured over Baseline, 30 days, 90 days
+2 more outcomes measured

Conditions

Alcohol Use, Unspecified
Relationship, Social
Depression, Anxiety

Explore related trials

Alcohol use disorderAnxietyDepression

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Gabriel R Murchison, PhD MPH · PRINCIPAL_INVESTIGATOR · Boston University

Who to contact

Gabriel R Murchison, PhD MPH
[email protected]
617-850-2905
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Able to read and write in English
Residency in the United States
Currently in a romantic relationship that began at least six weeks prior to enrollment

Exclusion

Referral source has generated other suspicious responses
Submitted within 48 hours of other responses with similar or identical content
Blank or nonsense response to at least one write-in question
Email address has pattern common in inauthentic responses (e.g., full name followed by a 3- or 4-digit number, last name followed by first name, or full name that appears unrelated to participant's stated name)
Reported nonstandard demographic information
Provided an email address with a domain other than gmail.com
Via Zoom, displaying a photo ID associated with the reported location (school/employer IDs acceptable)
Via Zoom, displaying a physical item associated with the reported location, such as a transit pass, library card, or university paraphernalia

What this trial measures

  • Alcoholic drinks per weekBaseline, 30 days, 90 days

    Average (mean) number of alcoholic drinks per week based on 14-day timeline followback, i.e., retrospective self-report of drinks per day.

  • Depression symptomsBaseline, 30 days, 90 days

    Self-report of depression symptoms in the prior 30 days, as measured by the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item questionnaire with each item scored from 0 to 3. Scores can range from 0 to 27 (scores of 5-9 are classified as mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; ≥ 20 as severe depression).

  • Anxiety symptomsBaseline, 30 days, 90 days

    Self-report of generalized anxiety symptoms in the prior 30 days, as measured by the Generalized Anxiety Disorder-7 (GAD-7). The GAD-7 is a 7-item instrument with each item scored between 0 and 3 where 0=not at all, and 3= nearly every day. Scores can range from 0 to 21 and are interpreted as-- scores 0-4: Minimal Anxiety, scores 5-9: Mild Anxiety, scores 10-14: Moderate Anxiety, and scores greater than 15: Severe Anxiety.